Development of nonspecific interstitial pneumonitis associated with long-term treatment of primary pulmonary hypertension with prostacyclin

被引：15

作者：

Kesten, S ^{[1
]}

Dainauskas, J ^{[1
]}

McLaughlin, V ^{[1
]}

Rich, S ^{[1
]}

机构：

[1] Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA

来源：

CHEST | 1999年 / 116卷 / 02期

关键词：

interstitial lung disease; primary pulmonary hypertension; prostacyclin;

D O I：

10.1378/chest.116.2.566

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A young woman with primary pulmonary hypertension presented with interstitial lung disease approximately 5 years after successful treatment with IV prostacyclin, The pathology was consistent with nonspecific interstitial pneumonitis and was unresponsive to steroids and immunosuppressive medications. We speculate that further cases of this syndrome may be reported as more patients are living beyond 5 years with prostacyclin.

引用

页码：566 / 569

页数：4

共 11 条

[1] A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension [J].

Barst, RJ ;

Rubin, LJ ;

Long, WA ;

McGoon, MD ;

Rich, S ;

Badesch, DB ;

Groves, BM ;

Tapson, VF ;

Bourge, RC ;

Brundage, BH ;

Koerner, SK ;

Langleben, D ;

Keller, CA ;

Murali, S ;

Uretsky, BF ;

Clayton, LM ;

Jobsis, MM ;

Blackburn, SD ;

Shortino, D ;

Crow, JW .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) :296-301

[2] SURVIVAL IN PRIMARY PULMONARY-HYPERTENSION WITH LONG-TERM CONTINUOUS INTRAVENOUS PROSTACYCLIN [J].

BARST, RJ ;

RUBIN, LJ ;

MCGOON, MD ;

CALDWELL, EJ ;

LONG, WA ;

LEVY, PS .

ANNALS OF INTERNAL MEDICINE, 1994, 121 (06) :409-415

[3] SURVIVAL IN PATIENTS WITH PRIMARY PULMONARY-HYPERTENSION - RESULTS FROM A NATIONAL PROSPECTIVE REGISTRY [J].

DALONZO, GE ;

BARST, RJ ;

AYRES, SM ;

BERGOFSKY, EH ;

BRUNDAGE, BH ;

DETRE, KM ;

FISHMAN, AP ;

GOLDRING, RM ;

GROVES, BM ;

KERNIS, JT ;

LEVY, PS ;

PIETRA, GG ;

REID, LM ;

REEVES, JT ;

RICH, S ;

VREIM, CE ;

WILLIAMS, GW ;

WU, M .

ANNALS OF INTERNAL MEDICINE, 1991, 115 (05) :343-349

[4] PRIMARY PULMONARY-HYPERTENSION - NATURAL-HISTORY AND THE IMPORTANCE OF THROMBOSIS [J].

FUSTER, V ;

STEELE, PM ;

EDWARDS, WD ;

GERSH, BJ ;

MCGOON, MD ;

FRYE, RL .

CIRCULATION, 1984, 70 (04) :580-587

[5] PULMONARY VENOOCCLUSIVE DISEASE - FATAL PROGRESSION OF PULMONARY-HYPERTENSION DESPITE STEROID-INDUCED REMISSION OF INTERSTITIAL PNEUMONITIS [J].

GILROY, RJ ;

TEAGUE, MW ;

LOYD, JE .

AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 143 (05) :1130-1133

[6] PRIMARY PULMONARY-HYPERTENSION - LENGTH OF SURVIVAL IN PATIENTS REFERRED FOR HEART-LUNG TRANSPLANTATION [J].

GLANVILLE, AR ;

BURKE, CM ;

THEODORE, J ;

ROBIN, ED .

CHEST, 1987, 91 (05) :675-681

[7] RESTRICTIVE VENTILATORY PATTERN IN PRECAPILLARY PULMONARY-HYPERTENSION [J].

HORN, M ;

RIES, A ;

NEVEU, C ;

MOSER, K .

AMERICAN REVIEW OF RESPIRATORY DISEASE, 1983, 128 (01) :163-165

[8] Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension [J].

McLaughlin, VV ;

Genthner, DE ;

Panella, MM ;

Rich, S .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (05) :273-277

[9] THE EFFECT OF HIGH-DOSES OF CALCIUM-CHANNEL BLOCKERS ON SURVIVAL IN PRIMARY PULMONARY-HYPERTENSION [J].

RICH, S ;

KAUFMANN, E ;

LEVY, PS .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (02) :76-81

[10] THE EFFECT OF VASODILATOR THERAPY ON THE CLINICAL OUTCOME OF PATIENTS WITH PRIMARY PULMONARY-HYPERTENSION [J].

RICH, S ;

BRUNDAGE, BH ;

LEVY, PS .

CIRCULATION, 1985, 71 (06) :1191-1196

← 1 2 →